Nevertheless, evaluation of both EBF3 promoter and gene body in WGBS data [18] (in Fig. 4) enabled us to examine the exact same CpG sites in normal and cancer tissues and cell lines, and the methylation changes were consistent with previously published data [9]. Here, EBF3 is linked to cancer.